Tag: Cancer: Prostate
ADT Plus Radiotherapy Ups Survival in Metastatic Prostate CA
Superior median, five-year OS for prostate RT plus ADT versus ADT alone in propensity score analyses
PSA Cut Point of ≥0.4 ng/mL Predicts Progression
Shows the strongest correlation between biochemical recurrence and subsequent systemic progression
Tasquinimod Improves Radiographic PFS in mCRPC
Does not improve overall survival in metastatic castration-resistant prostate cancer
Midlife PSA Levels Predict Future Lethal Prostate Cancer
PSA levels in midlife strongly predict future lethal prostate cancer risk in U.S. cohort
SBRT, Proton Beam Therapy Use Increasing for Prostate CA
Median cost of stereotactic body radiotherapy lower than IMRT or proton beam therapy
Patient Experience Linked to Urologic CA Surgical Outcomes
Less prolonged hospitalization, fewer nursing-sensitive complications in high-performing hospitals
Unrealistic Expectations for Many Men With Localized Prostate CA
Most patients underestimate life expectancy without treatment, overestimate gains of tx
AUA: BRCA Mutations May Play Role in Prostate Cancer
Multiple studies suggest they might
Mitochondrial Dysfunction May Explain Prostate Cancer Disparity
Mechanism may explain prostate cancer treatment resistance among African-American men
Diet Can Impact Aggressiveness of Prostate Cancer
Researchers also suggests that statins may help counteract harmful effect of fatty foods
